Does participation in an HIV vaccine efficacy trial affect risk behaviour in South Africa? - Wikidata - awgldk - TriplyDB

Does participation in an HIV vaccine efficacy trial affect risk behaviour in South Africa?

Does participation in an HIV vaccine efficacy trial affect risk behaviour in South Africa?

http://www.wikidata.org/entity/Q37617853

about

How common and frequent is heterosexual anal intercourse among South Africans? A systematic review and meta-analysis.HIV-1 vaccines: challenges and new perspectives Development of an HIV vaccine attitudes scale to predict HIV vaccine acceptability among vulnerable populations: L.A. VOICES Potential future impact of a partially effective HIV vaccine in a southern African setting.Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study The HVTN503/Phambili HIV vaccine trial: a comparison of younger and older participants.Complex immune correlates of protection in HIV-1 vaccine efficacy trials.Theory-Based Analysis of Interest in an HIV Vaccine for Reasons Indicative of Risk Compensation Among African American Women.

P2860

Q30854994-62059B4B-CDBD-4408-9743-371CDDD78881 Q33577972-B2A87724-67D8-49F4-BB82-FB4B68FB0DA2 Q34063486-1891FC73-F59F-40E5-A61B-D6A1507DCF67 Q34160133-D4BE65A3-3B53-4C9C-8743-2E4180E47CB5 Q34240204-CC234D52-3243-430C-AFF1-D161F3F21C15 Q37669530-62FA0D7E-613D-46EC-B049-00E5143C842F Q39108779-BD3F830D-CF80-4D0C-A4E2-B0F1D7CEA7BD Q47637929-471F73B2-9EDC-4CDD-96B5-DF77E0BE2D20

P2860

Does participation in an HIV vaccine efficacy trial affect risk behaviour in South Africa?

http://www.wikidata.org/entity/Q37617853

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 January 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Does participation in an HIV v ...... isk behaviour in South Africa?

@en

Does participation in an HIV v ...... isk behaviour in South Africa?

@nl

type

label

Does participation in an HIV v ...... isk behaviour in South Africa?

@en

Does participation in an HIV v ...... isk behaviour in South Africa?

@nl

prefLabel

Does participation in an HIV v ...... isk behaviour in South Africa?

@en

Does participation in an HIV v ...... isk behaviour in South Africa?

@nl

P1433

Q37617853-DB0EA291-27CE-4407-9C51-61C5EED58F41

P1476

Q37617853-3D6747ED-53B9-44D1-BCB9-AC5AEFC0A1A6

P2093

Q37617853-0FC6C4E8-ECC2-4A86-8476-DE2F161B3A8B

Q37617853-603B77BE-EC8F-4EE2-90B5-736DC9D7FAFD

Q37617853-6C0C3A9B-4EBA-4234-902F-0C5E6F765A55

Q37617853-71955995-C9FC-4C4D-8C4D-66E7CA050E41

Q37617853-B639CF60-C0F7-4785-86F4-367EC9599798

Q37617853-C116B593-FF3E-456D-BB16-10CB6A2F3153

Q37617853-C3921A9C-FAE4-4694-911C-42397293FC3E

Q37617853-D5D39F20-318B-4D6B-858F-992E7B0E7F65

P2860

Q37617853-0A71EDB5-3493-4336-B934-184B5FE8A3DC

Q37617853-0C0DFBD9-E768-406E-8226-C96716AE8D84

Q37617853-296D6E5A-B6E8-4A2B-A4AE-906AA2FBF8A9

Q37617853-365977A9-1E67-42AB-8D61-2A2F57C0FE6F

Q37617853-56295E48-8167-4551-A1F2-54715F0E2041

Q37617853-6CED70D5-178F-44F3-A7D9-0E82EEDD0710

Q37617853-B054B440-9E7E-4D14-8529-97EB48B1CC59

Q37617853-B159BFA2-A9BA-4ED4-98FB-D076E0DAD29E

Q37617853-B66CE6D0-3AED-42A8-9E10-C88B816D03BF

Q37617853-B85098BC-0A0D-434A-A393-6D7B038C553B

P304

Q37617853-4BEDBD37-9449-4C28-A442-4903CC13FCB1

P31

Q37617853-5459AC94-803B-4D36-9665-79AC6619102B

P356

Q37617853-2497DC8B-470C-4108-B06E-DADD5653458F

P407

Q37617853-44A3AE1D-6C2A-462B-801E-9AA2F0B9FAB8

P433

Q37617853-EF66748E-45A9-4066-B3B2-3959047A7DEA

P478

Q37617853-F9DE6E37-0E94-43EC-AD54-68901E8B55FA

P50

Q37617853-3127F35E-8F30-43E7-AF3C-984FB970B896

Q37617853-A0F7A7DF-7256-4DDC-B848-FEB3E61BBF5D

P577

Q37617853-7F7F1E7B-0866-4CD2-9DB1-10037C06AEFD

P5875

Q37617853-166CA59D-58B1-4992-9EAF-DF1885ACAFA2

P698

Q37617853-2B856F3B-FDA4-439B-8364-C042F38B8B4F

P921

Q37617853-E5CB0BEA-2CB9-4E23-9D2E-251FE03F9158

P932

Q37617853-107B7CBA-9A46-42B0-978A-8F19ABA7016F

P356

J.VACCINE.2013.01.031

P1433

P1476

Does participation in an HIV v ...... isk behaviour in South Africa?

@en

P2093

B Metch

http://www.w3.org/2001/XMLSchema#string

G Churchyard

http://www.w3.org/2001/XMLSchema#string

G E Gray

http://www.w3.org/2001/XMLSchema#string

HVTN 503 team

http://www.w3.org/2001/XMLSchema#string

J Kublin

http://www.w3.org/2001/XMLSchema#string

L-G Bekker

http://www.w3.org/2001/XMLSchema#string

M Nchabeleng

http://www.w3.org/2001/XMLSchema#string

Z Moodie

http://www.w3.org/2001/XMLSchema#string

P2860

Risk compensation in HIV prevention: Implications for vaccines, microbicides, and other biomedical HIV prevention technologies

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

Sexual risk compensation and HIV/STD transmission: empirical evidence and theoretical considerations.

Sexual risk behaviors, circumcision status, and preexisting immunity to adenovirus type 5 among men who have sex with men participating in a randomized HIV-1 vaccine efficacy trial: step study

Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study.

Risk compensation: the Achilles' heel of innovations in HIV prevention?

Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial

Changes in sexual risk behavior among participants in a PrEP HIV prevention trial.

P304

2089-2096

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VACCINE.2013.01.031

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-01-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235390957

http://www.w3.org/2001/XMLSchema#string

P698

23370155

http://www.w3.org/2001/XMLSchema#string

P921

Aafrikaa Kibbaa

P932

3942784

http://www.w3.org/2001/XMLSchema#string